Pfizer-BioNTech Covid-19 vaccine wins Swiss regulatory approval

ZURICH (Dec 19): Swiss drugs regulator Swissmedic has authorised the Covid-19 vaccine from Pfizer and partner BioNTech, the agency said on Saturday, calling it the world’s first such approval under a standard procedure.Two months after receiving the application, Swissmedic granted authorisation for the vaccine in a rolling review of documents being submitted.Other countries have already approved it for emergency use to help curb the global coronavirus pandemic.”The data available to date showed a comparable high level of efficacy in